Evaluation of changes in oral drug absorption in preterm and term neonates for Biopharmaceutics Classification System (BCS) class I and II compounds-Reference-Cited by-同舟云学术

Evaluation of changes in oral drug absorption in preterm and term neonates for Biopharmaceutics Classification System (BCS) class I and II compounds

Published:2015-10-30 Issue:1 Volume:81 Page:137-147
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Somani Amit A.¹,Thelen Kirstin²,Zheng Songmao¹,Trame Mirjam N.¹,Coboeken Katrin²,Meyer Michaela²,Schnizler Katrin²,Ince Ibrahim²,Willmann Stefan²,Schmidt Stephan¹

Affiliation:

1. Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy; University of Florida; Orlando FL USA

2. Computational Systems Biology; Bayer Technology Services GmbH; Leverkusen Germany

Funder

Bayer Technology Services

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12752/fullpdf

Reference63 articles.

1. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications;Blencowe;Lancet,2012

2. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000;Liu;Lancet,2009

3. 3.6 million neonatal deaths-what is progressing and what is not?;Lawn;Semin Perinatol,2010

4. Lancet neonatal survival steering team. 4 million neonatal deaths: when? Where? Why?;Lawn;Lancet,2005

5. Antibiotics for pre-term pre-labour rupture of membranes: prevention of neonatal deaths due to complications of pre-term birth and infection;Cousens;Int J Epidemiol,2010

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semi-crystalline materials for pharmaceutical fused filament fabrication: Dissolution and porosity;International Journal of Pharmaceutics;2024-03

2. Pharmacokinetic and Pharmacodynamic Considerations of Antibiotic Use in Neonates;Antibiotics;2023-12-18

3. Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities;Pharmaceutics;2023-11-03

4. Compatibility of Commonly Used Active Pharmaceutical Ingredients in a Ready-to-Use Oral Suspending Vehicle;Pharmaceutics;2023-09-26

5. 脂質メディアを利用した医薬品成分の共結晶形成;Journal of the Society of Powder Technology, Japan;2023-03-10